Yelin E H, Criswell L A, Feigenbaum P G
Rosalind Russell Medical Research Center for Arthritis, University of California, San Francisco 94143-0920, USA.
JAMA. 1996 Oct 2;276(13):1048-53.
To compare health care utilization and outcomes over an 11-year period among persons with rheumatoid arthritis (RA) in fee-for-service and prepaid group practice settings.
Cohort of persons with RA followed up for as long as 11 years. The principal measures were obtained from an annual structured telephone interview conducted by a trained survey worker.
Persons with RA presenting to a random sample of community rheumatologists in northern California.
Patients were enrolled in 2 cycles: in 1982 and 1983 and in 1989. Study rheumatologists listed all persons meeting criteria for RA presenting to their offices over a 1-month period. Of the 1062 so listed, we enrolled 1025, or 96.5%. Of the 1025 persons with RA, 227 (22.2%) reported receiving care in prepaid group practice settings.
As of the end of 1994, 5295 person-years of observation were available for the analysis of the annual level of the utilization and outcome measures; 341 persons had been followed up for all 11 years of the study. The main utilization outcomes measured included office visits, outpatient surgeries, hospital admissions, and painful joints.
The persons with RA in fee-for-service and prepaid group practice settings did not differ in the quantity of health care used in any 1 year for either RA or non-RA reasons. Among those followed up for all 11 years, the persons in fee-for-service and prepaid group practice settings did not differ in the cumulative quantity of health care used over the entire period of study. The 2 groups did not differ on any outcome measure on either an annual or long-term basis. The results of mortality analyses were inconsistent: using Kaplan-Meier estimates, the persons with RA in prepaid group practice settings survived significantly longer (P<.05 by long-rank test); using Cox proportional hazards methods, the proportion dying each year did not differ signficantly.
We could find no evidence that persons with RA in fee-for-service and prepaid group practice settings received different quantities of health care or experienced different outcomes on either an annual or long-term basis.
比较按服务收费和预付费团体医疗模式下类风湿关节炎(RA)患者在11年期间的医疗服务利用情况及结局。
对RA患者队列进行长达11年的随访。主要测量指标通过训练有素的调查人员进行的年度结构化电话访谈获得。
加利福尼亚北部社区风湿病学家随机样本中的RA患者。
患者分两个周期入组:1982年和1983年以及1989年。参与研究的风湿病学家列出了在1个月期间到其办公室就诊且符合RA标准的所有人员。在列出的1062人中,我们纳入了1025人,占96.5%。在1025例RA患者中,227例(22.2%)报告在预付费团体医疗模式下接受治疗。
截至1994年底,有5295人年的观察数据可用于分析年度医疗服务利用水平和结局指标;341人在研究的11年中均得到随访。主要测量的医疗服务利用结局包括门诊就诊、门诊手术、住院以及疼痛关节情况。
按服务收费和预付费团体医疗模式下的RA患者,在任何1年中因RA或非RA原因使用的医疗服务数量均无差异。在随访11年的患者中,按服务收费和预付费团体医疗模式下的患者在整个研究期间使用的医疗服务累计数量无差异。两组在年度或长期的任何结局指标上均无差异。死亡率分析结果不一致:使用Kaplan-Meier估计法,预付费团体医疗模式下的RA患者存活时间显著更长(对数秩检验P<0.05);使用Cox比例风险法,每年的死亡比例无显著差异。
我们没有发现证据表明按服务收费和预付费团体医疗模式下的RA患者在年度或长期接受的医疗服务数量不同或结局不同。